Abstract
Risch and Zhang (1995; Science 268: 1584-9) reported a simple sample size and power calculation approach for the Haseman-Elston method and based their computations on the null hypothesis of no genetic effect. We argue that the more reasonable null hypothesis is that of no recombination. For this null hypothesis, we provide a general approach for sample size and power calculations within the Haseman-Elston framework. We demonstrate the validity of our approach in a Monte-Carlo simulation study and illustrate the differences using data from published segregation analyses on body weight and heritability estimates on carotid artery artherosclerotic lesions.
| Original language | English |
|---|---|
| Journal | Biometrical Journal |
| Volume | 50 |
| Issue number | 2 |
| Pages (from-to) | 257-269 |
| Number of pages | 13 |
| ISSN | 0323-3847 |
| DOIs | |
| Publication status | Published - 04.2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'A general approach for sample size and power calculations based on the Haseman-Elston method'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver